Last reviewed · How we verify

NCT04936867: CARYSMA

The CArdiac Imaging RegistrY Study

Completed Last updated 6 January 2026
What this trial tests

trial in Coronary Artery Disease (CAD) in 100 participants. Completed in 1 January 2025.

Timeline
25 July 2017
Primary endpoint
1 January 2025
1 January 2025

Quick facts

Lead sponsorJohann Wolfgang Goethe University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date25 July 2017
Primary completion1 January 2025
Estimated completion1 January 2025
Sites1 location across Germany

Conditions studied

Sponsor

Johann Wolfgang Goethe University Hospital

Who can join

18 and older, any sex, with Coronary Artery Disease (CAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective longitudinal observational investigator-led single centre cohort study we will include patients undergoing cardio-CT for clinical reasons, to evaluate the role of cardio-CT terms of its diagnostic and prognostic value, as well as risk-benefit ratio. Particular aims include: 1. To determine the prevalence of CAD for age, gender, ethnicity relative to established risk models 2. To determine associations between CAD severity and plaque type and: 1. with traditional risk factors (arterial hypertension, diabetes, hypercholesterolemia, smoking) 2. blood markers of increased cardiovascular risk 3. To determine predictive associations of between CAD with outcome (endpoint definitions in appendix) 4. To determine the risk-benefit ratio (number of subsequent interventions, complications, radiation exposure, late onset of cancer diseases, etc).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease (CAD)

Currently open trials in the same condition.

Other Johann Wolfgang Goethe University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936867.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing